| Biobetters are biologics based on an innovative biologic but with improved properties. |
| Fusion proteins have been used in the biopharmaceutical industry for over 25 years to improve the pharmacokinetic properties of otherwise short-half-life biologics. |
| Biobetter fusion proteins with longer half-lives or with targeting moieties are being developed for several innovative biologic drugs. |